Navigation Links
Pharmaceutical Marketing Done Right: Archi-Tech Systems Unveils Version of Proven Analytics Solution for Campaign Management

WEST TRENTON, N.J., July 10 /PRNewswire/ -- Archi-Tech Systems, a leading provider of pharmaceutical data analytics and reporting solutions, today announced DART(TM) PromoTrack, a new solution custom-designed to rapidly measure the impact of pharmaceutical marketing campaigns and prescriber promotions. Archi-Tech has tailored its proven DART technology to meet the specific needs of pharmaceutical marketers, seamlessly integrating disparate promotional campaign and Rx sales data to facilitate on-the-fly analytics and reporting. For the first time, marketers have endless configurations of critical data at their fingertips to better monitor advertising, sampling, educational seminars, and other promotional tools for compliance and effectiveness.

"Pharmaceutical marketers are challenged to run successful campaigns under tight budgets and intense regulatory scrutiny. But with mountains of data to sift through, they often cannot properly measure the results of their promotions to adapt their strategies accordingly," said Prashant Kohli, Vice President of Sales and Marketing for Archi-Tech. "DART PromoTrack provides faster, more accurate insight into specific campaigns to improve planning, streamline targeting, enhance messaging, ensure compliance -- and ultimately maximize marketing dollars spent."

Built on the proven DART solution, already widely used by the pharmaceutical industry for instant, in-depth analytics and reporting on sales, marketing, and managed care data, DART PromoTrack offers unmatched flexibility to analyze and report on any configuration of data across the full scope of prescriber metrics and activity. This brings together Rx, call/sample, demographic, campaign, promotional, and other detail in a single view that encompasses millions of physicians and multiple markets and specialties. Pharmaceutical marketing teams can run multi-dimensional searches in seconds, conduct ad-hoc analyses, and generate instant reports on a wide range of datasets and parameters, regardless of volume or complexity. This yields actionable information to more effectively track marketing initiatives, manage control group activity, monitor trends, review results against actual performance, and more.

About Archi-Tech

Archi-Tech Systems is a leading provider of solutions for instant analytics and powerful reporting for pharmaceutical sales, marketing, and managed care departments. Balancing deep data expertise with advanced technology solutions and a unique service model, Archi-Tech addresses the full scope of a company's data analysis and reporting needs, no matter how simple or complex. The company's solutions offer unmatched speed and compression for any type of data, from any source, regardless of volume or complexity. In addition, the Archi-Tech team offers more than 100 years of combined experience with industry leading data vendors, and direct pharmaceutical client service experience. This translates to a unique understanding of the data, and exactly how our clients need to use it. For more information, visit

SOURCE Archi-Tech Systems
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Pacira Pharmaceuticals, Inc. Adds Board Member and Key Senior Management
2. Par Pharmaceutical to Launch meclizine HCL Tablets
3. Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President, Global Supply Chain and Sustainment Engineering
4. Lilly to Acquire SGX Pharmaceuticals
5. New MedPredict Report Highlights Trend Toward Early Diagnosis and Treatment of Rheumatoid Arthritis, Impact on Pharmaceutical Development
6. Pharmaceutical Institute, in Collaboration With Campbell Alliance, Releases Second Edition of Breakthrough Book on the Inner Workings of the Pharmaceutical Industry
7. Edison Pharmaceuticals Receives Commendation From the City of San Jose
8. Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poors Market Access Program
9. Transcept Pharmaceuticals Appoints Key Senior Executives
10. Addrenex Pharmaceuticals Licenses New Compound to Sciele Pharma for the Treatment of Hypertension and Other Potential Indications
11. Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... Matthew “Tex” VerMilyea, PhD, HCLD, has joined ... will oversee all IVF lab procedures as well as continue his research efforts into ... 7,305 miles to Auckland, New Zealand to bring home a High Complexity Clinical Laboratory ...
(Date:11/30/2015)... ... , ... Global Stem Cells Group Chile CEO ... America and abroad for the first Iberoamerican Convention on Aesthetic Medicine, Cosmetology and ... will present and discuss new trends in anti-aging stem cell treatments, regenerative medicine ...
(Date:11/30/2015)... ... 2015 , ... Global Stem Cells Group today ... Santiago Marriott. The Global Stem Cells Group GMP facility is equipped with the ... medical researchers and practitioners, experienced in administering stem cell protocols using highly manipulated ...
(Date:11/30/2015)... , Dec. 1, 2015  An interventional radiology technique shows ... the preliminary results of a study being presented today at ... North America (RSNA). --> ... for decades by interventional radiologists as a way to stop ... procedure as a means of treating obesity is new. ...
Breaking Biology Technology:
(Date:11/30/2015)... , Nov. 30, 2015  BIOCLAIM announced ... finalist in this year,s Fierce Innovation Awards:  Healthcare Edition, ... FierceHealthIT , FierceHealthcare , ... as a finalist in the category of "Privacy ... --> --> ...
(Date:11/19/2015)...  Based on its in-depth analysis of the biometric ... the 2015 Global Frost & Sullivan Award for Product ... this award to the company that has developed the ... the market it serves. The award recognizes the extent ... customer base demands, the overall impact it has in ...
(Date:11/18/2015)... ALBANY, New York , November 18, 2015 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2021. According to ... bn in 2014 and is anticipated to reach US$29.1 ... 2015 to 2021. North America ...
Breaking Biology News(10 mins):